NEWTOWN, Pa., July 28, 2024 /PRNewswire/ — Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Dexcom, Inc. (NASDAQ: DXCM) resulting from allegations of providing potentially misleading business information to the investing public. If you…
Month: July 2024
NEWTOWN, Pa., July 28, 2024 /PRNewswire/ — Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Dexcom, Inc. (NASDAQ: DXCM) resulting from allegations of providing potentially misleading business information to the investing public. If you…
NEWTOWN, Pa., July 28, 2024 /PRNewswire/ — Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Dexcom, Inc. (NASDAQ: DXCM) resulting from allegations of providing potentially misleading business information to the investing public. If you…
NEW YORK, July 28, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Allarity Therapeutics, Inc. (NASDAQ: ALLR) resulting from allegations that Allarity Therapeutics, Inc. may…
NEW YORK, July 28, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Allarity Therapeutics, Inc. (NASDAQ: ALLR) resulting from allegations that Allarity Therapeutics, Inc. may…
NEW YORK, July 28, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Allarity Therapeutics, Inc. (NASDAQ: ALLR) resulting from allegations that Allarity Therapeutics, Inc. may…
NEW YORK, July 28, 2024 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds investors a shareholder filed a class action lawsuit on behalf of all purchasers of securities of MongoDB, Inc. (NASDAQ: MDB) between August 31, 2023 and May 30, 2024. Shareholders who want…
PRINCETON, N.J., July 28, 2024 /PRNewswire/ — Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&D, manufacturing and sales of innovative medications, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s…
MUMBAI, Indien, 28. Juli 2024 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), ein weltweit führendes Pharmaunternehmen, gab heute seine Standalone- und konsolidierten Ergebnisse für das erste Quartal (Q1) zum 30. Juni 2024 bekannt. Konsolidierte finanzielle…
Puntos clave Los análisis de sangre que detectan de forma precisa y confiable los cambios cerebrales característicos del Alzheimer suponen un cambio hacia una detección y un diagnóstico más simples, precisos y tempranos, que podrían sustituir a los métodos actuales que son costosos,…